Straumann Holding stock

STMN · SIX · CHF

Compare Straumann Holding
CHF 108.75Change from previous close: +1.45%Absolute change: +CHF 1.55

Close · November 16, 2026

Price history

+10.87% over the period

1 year: from CHF 98.22 (November 17, 2025) to CHF 108.90 (November 16, 2026), +10.87%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026CHF 108.90
October 30, 2026CHF 97.42
September 30, 2026CHF 91.54
August 31, 2026CHF 93.90
July 31, 2026CHF 99.88
June 30, 2026CHF 106.40
May 29, 2026CHF 94.72
April 30, 2026CHF 84.50
March 31, 2026CHF 82.00
February 27, 2026CHF 92.60
January 30, 2026CHF 93.10
December 30, 2025CHF 93.46
November 28, 2025CHF 91.60
November 17, 2025CHF 98.22

At a glance

  • The company

    Develop and sell dental implants, prosthetics, orthodontic solutions and digital equipment for tooth replacement, restoration and correction

  • Latest results

    Quarter to September 30, 2026

TickerLandia's take on Straumann Holding

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowCHF 73.02
52-wk highCHF 109.90

−1.05% from the 52-week high

Analysts · 20 analysts

Average targetCHF 114.32+5.12% vs. price

Buy 13 · Hold 6 · Sell 1 · Buy

TickerLandia Fingerprint: Straumann Holding

Compared with similar companies: high profitability, high financial strength, and low growth.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Straumann Holding is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), Straumann Holding's P/E today is 48.8, above the median of its last 10 fiscal years (40.9; between 27.2 and 180.0 from 2016 to 2025). Straumann Holding's P/E (trailing 12 months): 47.1, +12% against the median of a group of 10 similar companies (41.9).

P/E compared with its history

Compared with 10 similar companies

Straumann Holding's metrics compared with similar companies
MetricStraumann HoldingPosition in the groupBand
P/E (trailing 12 months)47.1Middle
Forward P/E28.1Middle
Operating margin24.7%High
ROE17.0%Middle
Debt/equity0.21Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Straumann Holding. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

CHF 1.38B

Latest quarter · Q2 2026

Net income

CHF 249.7M

Latest quarter · Q2 2026

Quarterly net margin

18.1%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
CHF 17.35B
P/E
47.1
EPS
CHF 2.31
Volume
166.21K
Daily trading
€44.93M
Dividend yield
0.92%
Last ex-dividend on April 21, 2026

How Straumann Holding is changing

All results
  • Revenue grew 12.8% a year on average over the last 5 years

  • Operating margin rose from 23.7% to 25.1%

  • Profits turn into cash: free cash flow equal to 106% of net income

Returns

Straumann Holding returns with dividends

CHF 1,000 invested in Straumann Holding 5 years ago, on November 16, 2021, would be worth CHF 560 today with dividends reinvested: −44.00% in total, −10.95% per year. On price alone it would be CHF 539 (−46.09%).

PeriodStraumann HoldingSMICHF 1,000 becomes
1 month+16.07%+5.87%CHF 1,161
6 months+30.05%+15.25%CHF 1,301
Year to date+16.52%+14.84%CHF 1,165
1 year+12.11%+20.94%CHF 1,121
3 years−5.38%+43.15%CHF 946
5 years−44.00%+21.33%CHF 560
10 years+226.67%+92.52%CHF 3,267

Over the last 6 months it has done better than 47% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. SMI: price only. Calculate your investment

The chart in detail

Straumann Holding: technical analysis

Straumann Holding is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 47.6% below its all-time closing high (CHF 207.50, November 4, 2021).

Trend
Upward
RSI (14 sessions)
73
Above 70: a strong rise in a short time
vs 200-session average
+15.44%

Active signals

  • New 52-week high.

  • RSI above 70: the stock has risen a lot in a short time.

    since November 12, 2026

Support and resistance

Price areas where Straumann Holding has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. ResistanceCHF 109.48+0.67%2 touches, last on November 5, 2026
  2. Last priceCHF 108.75
  3. SupportCHF 105.10−3.36%2 touches, last on August 6, 2026
  4. SupportCHF 102.53−5.72%3 touches, last on July 2, 2026
  5. SupportCHF 99.76−8.26%2 touches, last on September 28, 2026

Volatility and risk

Over the last year it has moved roughly in line with the SMI.

Beta (1 year) vs SMI
0.98
Volatility (60 sessions, annualised)
26.6%
Largest fall in the last year
−24.84%

Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Straumann Holding: seasonality

Average monthly price change over 29 years

+1.2%Jan+2.4%Feb+0.2%Mar+3.7%Apr+2.6%May+0.9%Jun+1.1%Jul+2.1%Aug−0.7%Sep+1.7%Oct+1.4%Nov+3.4%Dec

Over the last 29 years, the strongest month for Straumann Holding has been April: +3.66% on average, positive in 18 years out of 28. The weakest has been September: −0.72% on average, positive in 14 years out of 29. November, the current month, has been positive in 18 years out of 28 (+1.43% on average).

Show chart data
MonthAverageMedianPositive years
January+1.24%+0.46%15 of 28
February+2.41%+1.62%16 of 28
March+0.16%+1.69%16 of 28
April+3.66%+1.72%18 of 28
May+2.58%+2.49%18 of 28
June+0.91%+1.30%15 of 28
July+1.11%−0.01%14 of 28
August+2.07%+1.74%17 of 29
September−0.72%−0.46%14 of 29
October+1.69%+2.80%17 of 29
November+1.43%+3.06%18 of 28
December+3.39%+1.23%17 of 28

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Straumann Holding and its competitors

Tooth replacement is the starting point of the business, with dental implants, implant components and surgical instruments sold alongside prosthetics, CADCAM solutions and digital equipment such as intraoral scanners and 3D printers. Orthodontic products, including clear aligners sold under ClearCorrect, form a second area, while regenerative materials, consumables and training complete the range.

Headquarters
Basel, Switzerland
Employees
11,582
Founded
1954
Chief executive
Guillaume Daniellot
Straumann Holding and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Straumann HoldingSTMN$20.69B24.7%47.1+30.05%
Sartorius Stedim BiotechDIM$24B19.2%67.0+44.45%
SartoriusSRT$19.89B17.8%79.3+37.44%
ColoplastCOLO.B$16.93B25.7%37.2+27.77%
AlconALC$35.8B12.9%57.3+23.24%
Ypsomed HoldingYPSN$6.77B36.2%34.3+44.57%

Same industry or related industries, similar size. Compare Straumann Holding with its competitors · Full profile